1062 related articles for article (PubMed ID: 14717618)
1. Efflux-mediated drug resistance in bacteria.
Li XZ; Nikaido H
Drugs; 2004; 64(2):159-204. PubMed ID: 14717618
[TBL] [Abstract][Full Text] [Related]
2. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
Hasdemir U
Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
[TBL] [Abstract][Full Text] [Related]
3. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
Wang Y; Venter H; Ma S
Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
[TBL] [Abstract][Full Text] [Related]
4. Multidrug efflux pumps of Gram-positive bacteria.
Schindler BD; Kaatz GW
Drug Resist Updat; 2016 Jul; 27():1-13. PubMed ID: 27449594
[TBL] [Abstract][Full Text] [Related]
5. Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective.
Alibert S; N'gompaza Diarra J; Hernandez J; Stutzmann A; Fouad M; Boyer G; Pagès JM
Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):301-309. PubMed ID: 27764576
[TBL] [Abstract][Full Text] [Related]
6. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists.
Aeschlimann JR
Pharmacotherapy; 2003 Jul; 23(7):916-24. PubMed ID: 12885104
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
[TBL] [Abstract][Full Text] [Related]
8. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.
Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV
Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084
[TBL] [Abstract][Full Text] [Related]
9. The development of efflux pump inhibitors to treat Gram-negative infections.
Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
[TBL] [Abstract][Full Text] [Related]
10. Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials.
Hernando-Amado S; Blanco P; Alcalde-Rico M; Corona F; Reales-Calderón JA; Sánchez MB; Martínez JL
Drug Resist Updat; 2016 Sep; 28():13-27. PubMed ID: 27620952
[TBL] [Abstract][Full Text] [Related]
11. [Significance of efflux pumps in multidrug resistance of Gram-negative bacteria].
Wiercińska O; Chojecka A; Kanclerski K; Rőhm-Rodowald E; Jakimiak B
Med Dosw Mikrobiol; 2015; 67(1):55-62. PubMed ID: 26084076
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of the over-expression of efflux pump in nonfermentative Gram-negative bacilli, development of efflux pump inhibitors.
Vila J; Martínez JL
Curr Drug Targets; 2008 Sep; 9(9):797-807. PubMed ID: 18781925
[TBL] [Abstract][Full Text] [Related]
13. Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gram-negative bacteria.
Butaye P; Cloeckaert A; Schwarz S
Int J Antimicrob Agents; 2003 Sep; 22(3):205-10. PubMed ID: 13678822
[TBL] [Abstract][Full Text] [Related]
14. Measuring the activity of active efflux in gram-negative bacteria.
Webber MA; Coldham NG
Methods Mol Biol; 2010; 642():173-80. PubMed ID: 20401594
[TBL] [Abstract][Full Text] [Related]
15. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
Nikaido H; Pagès JM
FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of bacterial efflux pumps on the antibacterial activity of the novel fluoroquinolone besifloxacin.
Shinabarger DL; Zurenko GE; Hesje CK; Sanfilippo CM; Morris TW; Haas W
J Chemother; 2011 Apr; 23(2):80-6. PubMed ID: 21571623
[TBL] [Abstract][Full Text] [Related]
17. Multiple antibiotic resistance and efflux.
Nikaido H
Curr Opin Microbiol; 1998 Oct; 1(5):516-23. PubMed ID: 10066525
[TBL] [Abstract][Full Text] [Related]
18. [Active efflux as the multidrug resistance mechanism].
Wasaznik A; Grinholc M; Bielawski KP
Postepy Hig Med Dosw (Online); 2009 Apr; 63():123-33. PubMed ID: 19373193
[TBL] [Abstract][Full Text] [Related]
19. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.
Lomovskaya O; Bostian KA
Biochem Pharmacol; 2006 Mar; 71(7):910-8. PubMed ID: 16427026
[TBL] [Abstract][Full Text] [Related]
20. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
